Takeda shareholder proposal against Shire buyout voted down

A shareholder proposal to stop Takeda Pharmaceutical's 46 billion pound ($62 billion) buyout of Irish drugmaker Shire Plc was voted down at the Japanese company's annual general meeting Thursday.The proposal put forth by a group of shareholders was aimed at changing Takeda's articles of incorporation to require advance shareholder approval for large acquisitions.Still, a tug of war between shareholders opposed to and in favor of the buyout is likely to continue until early next year, when the company is expected to call an extraordinary meeting of shareholders to vote on issuing many new sh…READ FULL ARTICLE